|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.76 USD | +9.06% |
|
+3.56% | -14.81% |
| Mar. 21 | Earnings Flash (ARMP) ARMATA PHARMACEUTICALS Reports Q4 Revenue $1.5M | MT |
| Mar. 21 | Armata Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Armata Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 69.05 million compared to USD 36.92 million a year ago. Basic loss per share from continuing operations was USD 1.91 compared to USD 1.08 a year ago.
Diluted loss per share from continuing operations was USD 1.91 compared to USD 1.08 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.81% | 99.77M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
ARMATA PHARMACEUTICALS, INC. 
